NCT01153633已完成4 期
Pilot, Randomised, Double-blind, Controlled Clinical Trial on the Combined Efficacy of Prontosan Wound Irrigation Solution and Prontosan Wound Gel in the Reduction in Size and Change in Bioburden of Hard-to-heal Venous Leg Ulcers
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 2
- 主要终点
- Absolute Change of Target Ulcer From Baseline to Last Visit
研究概览
简要总结
The primary objective of the study is to evaluate the efficacy of Prontosan® Wound Irrigation Solution and Prontosan® Wound Gel in the treatment of hard-to heal venous leg ulcers compared to control saline irrigation solution and inactive gel by showing a reduction in size over a 12 week period.
详细描述
SUMMARY
Sponsor: B. BRAUN Medical AG
Trade name: Prontosan® Wound Irrigation Solution Prontosan® Wound Gel
Active substance: Polihexanide (0.1%) Betaine (0.1%)
Study Duration (per patient):
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males and females aged > 18 who are able to give informed consent
- •Patients with a chronic venous leg ulcer at any location below the knee joint (CVI grade C6 according to CEAP classification = trophic lesions and open ulcer)
- •Venous leg ulcer present for ≥4 weeks
- •Surface area of the target ulcer ≥2cm2 and <100cm2 with the largest length not being >10cm
- •ABPI ≥ 0.7
排除标准
- •Age below 18 years
- •Females of child bearing potential who are not willing to use a method of highly effective contraception during the entire study
- •Pregnant or breast feeding women
- •Signs and symptoms of clinical infection, or current use of antiseptics or antibiotics
- •Involvement in other trials within the past 1 month
- •Sensitivity to any of the components of Prontosan® or dressing material
- •Intolerance to compression therapy
- •Active osteomyelitis in the ulceration area
- •Active rheumatoid or collagen disease of blood vessels treated with corticosteroids
- •Chronic diseases that could impact the course of the study (malicious cancer, TB, AIDS, mental illnesses)
- •Plasma protein below 4 g/dl
- •Anaemia: haemoglobin below 10 g/dl
- •Poorly controlled Diabetes (HBA1C > 12%)
结局指标
主要结局
Absolute Change of Target Ulcer From Baseline to Last Visit
时间窗: 12 weeks
Percent Change of Wound Size From Baseline to Last Visit
时间窗: 12 Weeks
Healing of Target Ulcer atV6/EOS
时间窗: 12 weeks
Number of ulcers healed at V6/EOS
次要结局
- Number of Different Microganisms at V6/EoS(12 Weeks)
- Pain(12 Weeks)
- Condition of Wound Bed(12 Weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effect of Prontosan Wound Irrigation Solution on Venous UlcersWound CareVenous Ulcer CareWound CleansingChronic Wound CareNCT01048307Calvary Hospital, Bronx, NY20
招募中
不适用
Effectiveness and Safety of Using Prontosan to Treat Bacterial BiofilmIrrigation SolutionChronic WoundPressure InjuryBurnsDiabetic Foot UlcerNCT06185465The First Hospital of Jilin University60
终止
不适用
Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)Wound of Lower Leg (Physical Finding)NCT03369756B. Braun Medical Inc.43
已完成
3 期
Efficacy of Prontosan Solution on Chronic UlcersChronic Wound CareWound CleansingPressure UlcerNCT01333670Associazione Infermieristica per lo studio delle Lesioni Cutanee289
进行中（未招募）
不适用
Randomised trial of Prontosan wound gel for prevention of exit site infection in peritoneal dialysis patientsEUCTR2006-006928-18-GBBarts and The London NHS Trust